Tag | Content |
---|
EnhancerAtlas ID | HS082-19189 |
Organism | Homo sapiens |
Tissue/cell | HCASMC |
Coordinate | chr2:128272610-128274660 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EGR1 | MA0162.3 | chr2:128273916-128273930 | CCCGCCCCCGCAAT | + | 6.22 | EGR3 | MA0732.1 | chr2:128273915-128273930 | CCCCGCCCCCGCAAT | + | 6.59 | EGR4 | MA0733.1 | chr2:128273915-128273931 | CCCCGCCCCCGCAATA | + | 6.31 | NKX2-5 | MA0063.2 | chr2:128274115-128274125 | ACCACTTGAG | + | 6.02 | Nkx3-2 | MA0122.3 | chr2:128273233-128273246 | ACAACCACTTAAA | + | 6.57 | Nr2f6(var.2) | MA0728.1 | chr2:128274122-128274137 | GAGGTCAGGAGTTCA | + | 6.22 | TCF7L2 | MA0523.1 | chr2:128274597-128274611 | AAACATCAAAGAGA | + | 6.86 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_19088 | chr2:128273141-128274034 | CD4p_CD25-_Il17-_PMAstim_Th | SE_46469 | chr2:128271234-128277243 | Osteoblasts |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I127514 | chr2 | 128272261 | 128274958 |
|
Enhancer Sequence | CTTTGAAAGC AATTCCAATA GCTGCATTGC CATTTTTATA AATGTTCTAT TTACAGTTTA 60 ATCACTCATT TTCTACATTG TTGAGTATTT GTTTCCTTTC TTATGTTTAT TACACCTCAT 120 TTGTCCATTT CAGTGTTTTC AACCCAAGGG CGGCTCTGGG TCTTCACCCA AGGGGTTAGT 180 GGGAAATTCG AGGGGCTGTT TTTGGTCATC AATGATGGGG AGGATGTGTT ACTAGCATTT 240 CATTTAATGC CCAGTAACCA AGATGCTAAA TGTCCTGTTA ATATACAGGC ATGCCCCCAA 300 ATATCCACAA CTGGCTTGCT AAAAATCTCT TGTTCAGGAA AGCAACACAA GGCTGCTCTC 360 TCTGGAGGTG TGGCCACAGG CAGGACCCGG AGGTCCTCAC CCATACACAC ATAGAGGAAA 420 CTCCATGAGA TGAAAGAGCT CAATGGGCCC AATACAGATT GCGCTAACAG ACAAGAGAAG 480 CATAATAGGT CCCTTTGGGA TTTAAACTGG GGAATATGCA AAAGCCTGAC CAATCTGTAA 540 GAGATAAACA AGAAGTCAAA CAAGGACTTT TGGCATCACA GAATGAGAAG CTCTACCGAC 600 CTCCCCAGTG AAAATTATTA AAAACAACCA CTTAAAGCCT CTACAAATGG TCCTAACGGC 660 AAAGGGCAAA TGAAGAAACG CCTACACAAA TTCCACAAGA GAGATTACTT GAACCAAGAT 720 CAATCCCTCC TTCCAACCTC ACAATTCAGT GAGGCTGACT CCACTCCAGA TTGCTGCAGC 780 CAGAAATACA GAGTTCCTTC TCCATCCTGC TTCAGTTAGA GGGCTTCCTT CCCAGGAAGA 840 GCAGGGCATC AGCATCTCTC ATCCGGCTCC CCAGTGCCTG CTGCTGTGGC TAAGTTCCGA 900 AAGACTGCAG TTGAGAAGTG GAGATTCCCA TCTTTTGCCC AACCCTCACT TGCTTAAAGA 960 AGGCTCTACC TTGGGTGGAC CACACTGAGA ATACTGGGGC CCTAATCACC CTTGGGCCGG 1020 CTTGTGAGAC CATGCCAAGA GATGCAAGCT GAAAGGATTT CAGGTTACTA ACTCATTCCC 1080 ACTCCTCCAC TCCCTACCCA GAGCTCAGTG TTTAAAAAAA TACAGAAGGC AGCCTAGGCA 1140 ACGTGGCAAA ACTCCATGTC TACAACACAA AAATTAGCTG GGCGTGTGGT GTATGCCTGT 1200 GGTCCCAACC ACTAAGGAGT CTGAGGCAGG AGAATCTCTT CAACCTGGGC AGTGAGCCGA 1260 GATCGCGTCA TGGCACTCCA GCCTGGGCGA CAGTGAGACT CCGCACCCCG CCCCCGCAAT 1320 ACACACACAC AAAATAGAAA AGGAGAAAAC AGCTGAATAG AATTACTAGA CATAAGCTCA 1380 ATGAGAAAAA AAAGAGGACT TCAACAATAC TATAAATCAA CTAAATCAGA TATCTAAAGA 1440 AATAGGCCTG GCACAATGGC TCACACGTGT AATCCCAGTA CTGCTGAGAG GCCAGGGTGG 1500 GAGGAACCAC TTGAGGTCAG GAGTTCAAGA CCAGCCTGGG CAACATAGCA AAATCCCTCT 1560 CCACAAAAAT TTTAAAATTA GCCAGGCATG ATGGTACGCA ACTGTAGTCC TGGCTACTCA 1620 GAGGTATGAG GCGGGAAGAC TCCTTGTGCC CAGGAGTTCA AGGTTACAAT GAGCCATAAT 1680 TTTTTCACAT GCCCGCTGTG TCAAAGTGAG CCACAAATAC ACCACTGCAC TCCAACCTAG 1740 GCAACAGAAG AGACCTTTTT TAAAAACAAA ACAAAACCTT TATTCAACAA TATATATTCT 1800 TATTAAGCGC ATGGAACATT CTCCAGGATA GACTATGTGC TAGGCCCTAA AACAAACCCT 1860 GACAAATTTA AAAGAATAGC AATATACAAG GTTTGTTCCC CCACTACAAT GAAATAAGAT 1920 TAGAAATAGT AGGAAAAGTG TTTAGGAACA ATATGAATAT GAAATTAGTA AGATAATTCC 1980 ATTTACTAAA CATCAAAGAG AATAACATAA ATTTAACAAA GAAATCGAAC ATGTATACAC 2040 GGAAAACTAT 2050
|